The massive drug and opioid problem in the United States has been in full effect since 2013, and with the overflowing amount of lethal fentanyl crossing our unsecured borders, it seems to show no signs of stopping.
According to CDC estimates, in 2021 alone, more than 71,000 people have died from synthetic opioids – an 18% increase from 2020.
The window between someone potentially overdosing and actual death is minuscule – how someone reacts between that time is crucial.
The Food and Drug Administration (FDA) on Wednesday approved the sale of Narcan – a nasal spray used to reverse opioid overdoses – with no prescription needed.
In blocking the effect that opioids have on the nervous system, Narcan has been widely known to treat users on the brink of overdosing.
This decision would mean easier access to lifesaving treatment. FDA Commissioner Dr. Robert Califf said in a statement that the agency is encouraging the company to make the nasal spray affordable and available as soon as possible.
According to drug-store chain Walgreens, Narcan will be sold over the counter in their stores, later this year. According to the manufacturer, the 4 milligram dosage will be available this summer.
“Delivering access to this lifesaving medication that can reverse the effects of an overdose if administered in time is imperative and Walgreens is already working with suppliers to bring this OTC medication to shelves,” said Zoe Krey, a Walgreens spokesperson.
“We are dedicated to improving public health and assisting those working hard to end the opioid crisis— so now with leaders across government, retail and advocacy groups, we must work together to continue increasing access and availability,” Emergent President and CEO Robert Kramer said in a statement.
Add comment